Basic & Clinical Medicine ›› 2023, Vol. 43 ›› Issue (12): 1881-1885.doi: 10.16352/j.issn.1001-6325.2023.12.1881

• Mini Reviews • Previous Articles     Next Articles

Research progress on the role of thrombospondin 2 in malignant tumors

MA Jiajunyan1,2, RUI Tiannan1,2, ZHANG Yongsheng1*   

  1. 1. Department of Pathology, the Second Affiliated Hospital of Soochow University, Suzhou 215004;
    2. Department of Clinical Medicine, Suzhou Medical College, Soochow University, Suzhou 215123, China
  • Received:2023-04-26 Revised:2023-09-28 Online:2023-12-05 Published:2023-11-29
  • Contact: * shengyongzh@126.com

Abstract: Thrombospondin 2 (THBS2) is a matrix cell calcium-binding glycoprotein that interacts with a variety of growth factors, receptors, matrix molecules or proteases on the extracellular matrix and cell surface. THBS2 can be activated by N6-methyladenosyl RNA methylase, and mediates tumor proliferation, migration and invasion by remodeling the tumor microenvironment and participating in multiple cell signaling pathways. THBS2 could be used as a diagnostic and prognostic indicator for a variety of tumors, and is expected to become a new target for malignant tumor treatment.

Key words: thrombospondin, thrombospondin 2, carcinoma

CLC Number: